Coeptis，S-4歸檔和Z Squared：有什麼交易？

Coeptis提交與Z平方合併有關的S-4。這篇博客文章打破了對投資者的意義。

Coeptis, S-4 Filing, and Z Squared: What's the Deal?

Coeptis，S-4歸檔和Z Squared：有什麼交易？

Coeptis Therapeutics is merging with Z Squared! The company filed an S-4 registration statement with the SEC. Here's a quick look at what this means.

Coeptis Therapeutics與Z平方合併！該公司向SEC提交了S-4註冊聲明。這是一個快速查看這意味著什麼。

The Latest: Coeptis Files S-4 for Z Squared Merger (June 2025)

最新：Z平方合併的Coeptis文件S-4（2025年6月）

Coeptis Therapeutics Holdings, Inc. (COEP) has officially filed a registration statement on Form S-4 with the Securities and Exchange Commission (SEC) regarding its proposed merger with Z Squared Inc. This S-4 includes a preliminary proxy statement/prospectus, meaning things are moving forward, but it's not a done deal yet. The SEC still needs to give it the thumbs up.

Coeptis Therapeutics Holdings，Inc。 （COEP）已就其與Z Squared Inc.擬議的合併有關S-4的S-4表格S-4的註冊聲明。此S-4此S-4包括初步代理聲明/招股說明書，這意味著事情正在發展，但還沒有完成交易。 SEC仍然需要給它豎起大拇指。

Who Are These Companies Anyway?

這些公司是誰？

Let's break down who's who in this merger:

讓我們分解此合併中的誰：

• Coeptis Therapeutics: A biopharmaceutical company focused on cell therapy platforms for cancer, autoimmune, and infectious diseases. They've also got a tech division dabbling in AI-powered marketing and robotic process automation.
• Z Squared Inc: They're all about digital asset compute mining, specifically focusing on Dogecoin (DOGE) and other altcoins.

Why Should You Care?

你為什麼要關心？

This merger could mean a significant shift for both companies. Coeptis gets a new revenue stream in the digital asset space, while Z Squared gains access to Coeptis' resources and expertise in the biotech world. For investors, it's a blend of healthcare innovation and crypto mining – a potentially interesting combo.

這次合併可能意味著兩家公司的重大轉變。 Coeptis在數字資產領域獲得了新的收入來源，而Z Squared可以在生物技術世界中獲得Coeptis的資源和專業知識。對於投資者而言，這是醫療創新和加密礦業開采的融合，這是一個可能有趣的組合。

What's Next?

接下來是什麼？

Coeptis urges investors to read the preliminary proxy statement/information statement/prospectus as well as other documents filed with the SEC because these documents contain important information about Coeptis, Z Squared and the proposed transaction. The preliminary and definitive proxy statement/information statement/prospectus to be included in the registration statement, once available, can be obtained, without charge, at the SEC’s website (www.sec.gov).

Coeptis敦促投資者閱讀初步替代聲明/信息聲明/招股說明書以及向SEC提交的其他文件，因為這些文件包含有關Coeptis，Z Squared和擬議交易的重要信息。在SEC的網站（www.sec.gov）上，可以在不收取的註冊聲明中包含的初步和確定的代理聲明/信息聲明/招股說明/招股說明書。

The Fine Print (aka Forward-Looking Statements)

精美的打印（又稱前瞻性語句）

As with any announcement like this, there are forward-looking statements involved. These are basically educated guesses about the future, and they come with risks and uncertainties. Don't take everything you read as gospel. Do your own research, folks!

與此類公告一樣，涉及前瞻性陳述。這些基本上是對未來的猜測，並且會帶來風險和不確定性。不要以您閱讀的所有內容為福音。做自己的研究，伙計們！

Final Thoughts: A Biopharma Company Mining Dogecoin?

最終想法：一家生物製藥公司挖掘狗狗幣？

Honestly, who saw that coming? It's a wild combination, but in today's market, you've gotta stay on your toes. Whether this merger is a stroke of genius or a recipe for disaster remains to be seen. One thing's for sure: it's going to be an interesting ride!

老實說，誰看到了那個？這是一種瘋狂的組合，但是在當今的市場中，您必須留在腳趾上。這次合併是天才的中風還是災難的秘訣，還有待觀察。可以肯定的是：這將是一個有趣的旅程！